1. Home
  2. RCAT vs CAPR Comparison

RCAT vs CAPR Comparison

Compare RCAT & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$10.46

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$23.21

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
CAPR
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
RCAT
CAPR
Price
$10.46
$23.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$20.00
$44.63
AVG Volume (30 Days)
12.3M
1.5M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,836,382.00
N/A
Revenue This Year
$271.60
N/A
Revenue Next Year
$41.21
$3.31
P/E Ratio
N/A
N/A
Revenue Growth
79.95
N/A
52 Week Low
$5.77
$4.30
52 Week High
$18.78
$40.37

Technical Indicators

Market Signals
Indicator
RCAT
CAPR
Relative Strength Index (RSI) 46.61 34.38
Support Level $9.08 $22.09
Resistance Level $13.69 $30.39
Average True Range (ATR) 0.94 1.58
MACD -0.06 -0.40
Stochastic Oscillator 46.88 8.10

Price Performance

Historical Comparison
RCAT
CAPR

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: